Pliant Therapeutics Inc (PLRX)
12.98
+0.13
(+1.01%)
USD |
NASDAQ |
Nov 22, 16:00
12.99
+0.01
(+0.08%)
After-Hours: 20:00
Pliant Therapeutics Market Cap: 789.88M for Nov. 22, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 22, 2024 | 789.88M |
| November 21, 2024 | 781.97M |
| November 20, 2024 | 774.67M |
| November 19, 2024 | 778.32M |
| November 18, 2024 | 749.72M |
| November 15, 2024 | 756.41M |
| November 14, 2024 | 781.97M |
| November 13, 2024 | 837.95M |
| November 12, 2024 | 841.00M |
| November 11, 2024 | 882.99M |
| November 08, 2024 | 912.80M |
| November 07, 2024 | 924.37M |
| November 06, 2024 | 955.40M |
| November 05, 2024 | 906.72M |
| November 04, 2024 | 881.77M |
| November 01, 2024 | 883.59M |
| October 31, 2024 | 856.15M |
| October 30, 2024 | 876.84M |
| October 29, 2024 | 895.70M |
| October 28, 2024 | 904.22M |
| October 25, 2024 | 861.02M |
| October 24, 2024 | 832.42M |
| October 23, 2024 | 864.67M |
| October 22, 2024 | 890.23M |
| October 21, 2024 | 892.05M |
| Date | Value |
|---|---|
| October 18, 2024 | 924.91M |
| October 17, 2024 | 892.66M |
| October 16, 2024 | 920.04M |
| October 15, 2024 | 851.89M |
| October 14, 2024 | 835.46M |
| October 11, 2024 | 830.60M |
| October 10, 2024 | 705.85M |
| October 09, 2024 | 698.55M |
| October 08, 2024 | 683.95M |
| October 07, 2024 | 676.65M |
| October 04, 2024 | 701.59M |
| October 03, 2024 | 676.65M |
| October 02, 2024 | 663.87M |
| October 01, 2024 | 641.96M |
| September 30, 2024 | 682.12M |
| September 27, 2024 | 687.66M |
| September 26, 2024 | 679.15M |
| September 25, 2024 | 688.88M |
| September 24, 2024 | 688.88M |
| September 23, 2024 | 688.27M |
| September 20, 2024 | 738.13M |
| September 19, 2024 | 767.31M |
| September 18, 2024 | 760.02M |
| September 17, 2024 | 766.10M |
| September 16, 2024 | 721.71M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
148.66M
Minimum
May 11 2022
2.051B
Maximum
Jan 31 2023
901.12M
Average
901.19M
Median
Market Cap Benchmarks
| Haemonetics Corp | 4.297B |
| Marker Therapeutics Inc | 27.66M |
| Aligos Therapeutics Inc | 71.90M |
| Korro Bio Inc | 490.06M |
| CEL-SCI Corp | 36.64M |
Market Cap Related Metrics
| PS Ratio | 155.71 |
| Price to Book Value | 2.284 |
| Price | 12.98 |
| Earnings Yield | -25.73% |